BRIEF-GlaxoSmithKline seeks U.S. approval for melanoma drug combination

LONDON, July 9 Tue Jul 9, 2013 2:06am EDT

LONDON, July 9 (Reuters) - GlaxoSmithKline Plc : * GSK announces U.S. submission for dabrafenib/trametinib combination in

metastatic melanoma

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.